Integrated transcriptome analysis reveals miRNA-mRNA crosstalk in laryngeal squamous cell carcinoma

Genomics

Volumn 104, Issue 4, 2014, Pages 249-256

  Zhang, Yang ^a   Chen, Yong ^b   Yu, Jinhai ^b   Liu, Guiming ^c   Huang, Zhigang ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b INSTITUTE OF BIOPHYSICS   (China)

^c Chinese Academy of Sciences and China National Center for Bioinformation   (China)

Author keywords

Data integration; Gene expression; Laryngeal squamous cell carcinoma; Small RNAs

Indexed keywords

MESSENGER RNA; MICRORNA; MICRORNA 34C; UNCLASSIFIED DRUG; MITOCHONDRIAL DNA; TRANSCRIPTOME;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN GENOME; HUMAN TISSUE; LARYNX SQUAMOUS CELL CARCINOMA; MALE; MITOCHONDRIAL GENE; SQUAMOUS CELL CARCINOMA CELL; TRANSCRIPTOMICS; DNA SEQUENCE; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETICS; HIGH THROUGHPUT SEQUENCING; LARYNX TUMOR; MUTATION RATE; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; DNA, MITOCHONDRIAL; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; LARYNGEAL NEOPLASMS; MICRORNAS; MUTATION RATE; RNA, MESSENGER; SEQUENCE ANALYSIS, DNA; TRANSCRIPTOME;

EID: 84908229466     PISSN: 08887543     EISSN: 10898646     Source Type: Journal    
DOI: 10.1016/j.ygeno.2014.06.004     Document Type: Article

References (47)

1. Agrawal N., Frederick M.J., Pickering C.R., Bettegowda C., Chang K., Li R.J., Fakhry C., Xie T.X., Zhang J., Wang J., Zhang N., El-Naggar A.K., Jasser S.A., Weinstein J.N., Trevino L., Drummond J.A., Muzny D.M., Wu Y., Wood L.D., Hruban R.H., Westra W.H., Koch W.M., Califano J.A., Gibbs R.A., Sidransky D., Vogelstein B., Velculescu V.E., Papadopoulos N., Wheeler D.A., Kinzler K.W., Myers J.N. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science 2011, 333:1154-1157.
2. Stransky N., Egloff A.M., Tward A.D., Kostic A.D., Cibulskis K., Sivachenko A., Kryukov G.V., Lawrence M.S., Sougnez C., McKenna A., Shefler E., Ramos A.H., Stojanov P., Carter S.L., Voet D., Cortes M.L., Auclair D., Berger M.F., Saksena G., Guiducci C., Onofrio R.C., Parkin M., Romkes M., Weissfeld J.L., Seethala R.R., Wang L., Rangel-Escareno C., Fernandez-Lopez J.C., Hidalgo-Miranda A., Melendez-Zajgla J., Winckler W., Ardlie K., Gabriel S.B., Meyerson M., Lander E.S., Getz G., Golub T.R., Garraway L.A., Grandis J.R. The mutational landscape of head and neck squamous cell carcinoma. Science 2011, 333:1157-1160.
3. Leemans C.R., Braakhuis B.J., Brakenhoff R.H. The molecular biology of head and neck cancer. Nat. Rev. Cancer 2011, 11:9-22.
4. Fanjul-Fernandez M., Quesada V., Cabanillas R., Cadinanos J., Fontanil T., Obaya A., Ramsay A.J., Llorente J.L., Astudillo A., Cal S., Lopez-Otin C. Cell-cell adhesion genes CTNNA2 and CTNNA3 are tumour suppressors frequently mutated in laryngeal carcinomas. Nat. Commun. 2013, 4:2531.
5. Ma L.J., Li W., Zhang X., Huang D.H., Zhang H., Xiao J.Y., Tian Y.Q. Differential gene expression profiling of laryngeal squamous cell carcinoma by laser capture microdissection and complementary DNA microarrays. Arch. Med. Res. 2009, 40:114-123.
6. Ayaz L., Gorur A., Yaroglu H.Y., Ozcan C., Tamer L. Differential expression of microRNAs in plasma of patients with laryngeal squamous cell carcinoma: potential early-detection markers for laryngeal squamous cell carcinoma. J. Cancer Res. Clin. Oncol. 2013, 139:1499-1506.
7. Esteller M. Non-coding RNAs in human disease. Nat. Rev. Genet. 2011, 12:861-874.
8. Croce C.M., Calin G.A. miRNAs, cancer, and stem cell division. Cell 2005, 122:6-7.
9. Shen Z., Zhan G., Ye D., Ren Y., Cheng L., Wu Z., Guo J. MicroRNA-34a affects the occurrence of laryngeal squamous cell carcinoma by targeting the antiapoptotic gene survivin. Med. Oncol. 2012, 29:2473-2480.
10. Guo Y., Fu W., Chen H., Shang C., Zhong M. miR-24 functions as a tumor suppressor in Hep2 laryngeal carcinoma cells partly through down-regulation of the S100A8 protein. Oncol. Rep. 2012, 27:1097-1103.
11. Langevin S.M., Stone R.A., Bunker C.H., Lyons-Weiler M.A., LaFramboise W.A., Kelly L., Seethala R.R., Grandis J.R., Sobol R.W., Taioli E. MicroRNA-137 promoter methylation is associated with poorer overall survival in patients with squamous cell carcinoma of the head and neck. Cancer 2011, 117:1454-1462.
12. Pierini S., Jordanov S.H., Mitkova A.V., Chalakov I.J., Melnicharov M.B., Kunev V., Mitev V.I., Kaneva R.P., Goranova T.E. Promoter hypermethylation of CDKN2A, MGMT, MLH1, and DAPK genes in laryngeal squamous cell carcinoma and their associations with clinical profiles of the patients. Head Neck 2013, 10.1002/hed.23413.
13. Wong T.S., Gao W., Li Z.H., Chan J.Y., Ho W.K. Epigenetic dysregulation in laryngeal squamous cell carcinoma. J. Oncol. 2012, 2012:739461.
14. Wang E. Understanding genomic alterations in cancer genomes using an integrative network approach. Cancer Lett. 2013, 340:261-269.
15. Chen Y., Hao J., Jiang W., He T., Zhang X., Jiang T., Jiang R. Identifying potential cancer driver genes by genomic data integration. Sci. Rep. 2013, 3:3538.
16. Zaman N., Li L., Jaramillo M.L., Sun Z., Tibiche C., Banville M., Collins C., Trifiro M., Paliouras M., Nantel A., O'Connor-McCourt M., Wang E. Signaling network assessment of mutations and copy number variations predict breast cancer subtype-specific drug targets. Cell Rep. 2013, 5:216-223.
17. Wang K., Diskin S.J., Zhang H., Attiyeh E.F., Winter C., Hou C., Schnepp R.W., Diamond M., Bosse K., Mayes P.A., Glessner J., Kim C., Frackelton E., Garris M., Wang Q., Glaberson W., Chiavacci R., Nguyen L., Jagannathan J., Saeki N., Sasaki H., Grant S.F., Iolascon A., Mosse Y.P., Cole K.A., Li H., Devoto M., McGrady P.W., London W.B., Capasso M., Rahman N., Hakonarson H., Maris J.M. Integrative genomics identifies LMO1 as a neuroblastoma oncogene. Nature 2011, 469:216-220.
18. Eisen M.B., Spellman P.T., Brown P.O., Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:14863-14868.
19. Dennis G., Sherman B.T., Hosack D.A., Yang J., Gao W., Lane H.C., Lempicki R.A. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol. 2003, 4:P3.
20. Langmead B., Trapnell C., Pop M., Salzberg S.L. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 2009, 10:R25.
21. Friedlander M.R., Chen W., Adamidi C., Maaskola J., Einspanier R., Knespel S., Rajewsky N. Discovering microRNAs from deep sequencing data using miRDeep. Nat. Biotechnol. 2008, 26:407-415.
22. Corney D.C., Flesken-Nikitin A., Godwin A.K., Wang W., Nikitin A.Y. MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth. Cancer Res. 2007, 67:8433-8438.
23. Hermeking H. MicroRNAs in the p53 network: micromanagement of tumour suppression. Nat. Rev. Cancer 2012, 12:613-626.
24. Betel D., Wilson M., Gabow A., Marks D.S., Sander C. The microRNA.org resource: targets and expression. Nucleic Acids Res. 2008, 36:D149-D153.
25. Friedman R.C., Farh K.K., Burge C.B., Bartel D.P. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009, 19:92-105.
26. Fang L., Yang N., Ma J., Fu Y., Yang G.S. microRNA-1301-mediated inhibition of tumorigenesis. Oncol. Rep. 2012, 27:929-934.
27. Rhodes D.R., Chinnaiyan A.M. Integrative analysis of the cancer transcriptome. Nat. Genet. 2005, 37:S31-S37. (Suppl.).
28. Barabasi A.L., Gulbahce N., Loscalzo J. Network medicine: a network-based approach to human disease. Nat. Rev. Genet. 2011, 12:56-68.
29. Knauff E.A., Franke L., van Es M.A., van den Berg L.H., van der Schouw Y.T., Laven J.S., Lambalk C.B., Hoek A., Goverde A.J., Christin-Maitre S., Hsueh A.J., Wijmenga C., Fauser B.C. Genome-wide association study in premature ovarian failure patients suggests ADAMTS19 as a possible candidate gene. Hum. Reprod. 2009, 24:2372-2378.
30. Qi Y., Chiu J.F., Wang L., Kwong D.L., He Q.Y. Comparative proteomic analysis of esophageal squamous cell carcinoma. Proteomics 2005, 5:2960-2971.
31. Chandran U.R., Ma C., Dhir R., Bisceglia M., Lyons-Weiler M., Liang W., Michalopoulos G., Becich M., Monzon F.A. Gene expression profiles of prostate cancer reveal involvement of multiple molecular pathways in the metastatic process. BMC Cancer 2007, 7:64.
32. Oshima Y., Ueda M., Yamashita Y., Choi Y.L., Ota J., Ueno S., Ohki R., Koinuma K., Wada T., Ozawa K., Fujimura A., Mano H. DNA microarray analysis of hematopoietic stem cell-like fractions from individuals with the M2 subtype of acute myeloid leukemia. Leukemia 2003, 17:1990-1997.
33. Mese H., Sasaki A., Nakayama S., Yoshioka N., Yoshihama Y., Kishimoto K., Matsumura T. Prognostic significance of heat shock protein 27 (HSP27) in patients with oral squamous cell carcinoma. Oncol. Rep. 2002, 9:341-344.
34. Trautinger F., Kokesch C., Herbacek I., Knobler R.M., Kindas-Mugge I. Overexpression of the small heat shock protein, hsp27, confers resistance to hyperthermia, but not to oxidative stress and UV-induced cell death, in a stably transfected squamous cell carcinoma cell line. J. Photochem. Photobiol. B Biol. 1997, 39:90-95.
35. Sorensen C.B., Ladekjaer-Mikkelsen A.S., Andresen B.S., Brandrup F., Veien N.K., Buus S.K., Anton-Lamprecht I., Kruse T.A., Jensen P.K., Eiberg H., Bolund L., Gregersen N. Identification of novel and known mutations in the genes for keratin 5 and 14 in Danish patients with epidermolysis bullosa simplex: correlation between genotype and phenotype. J. Invest. Dermatol. 1999, 112:184-190.
36. Jerabkova B., Marek J., Buckova H., Kopeckova L., Vesely K., Valickova J., Fajkus J., Fajkusova L. Keratin mutations in patients with epidermolysis bullosa simplex: correlations between phenotype severity and disturbance of intermediate filament molecular structure. Br. J. Dermatol. 2010, 162:1004-1013.
37. Watson C.T., Breden F. The immunoglobulin heavy chain locus: genetic variation, missing data, and implications for human disease. Genes Immun. 2012, 13:363-373.
38. Wallace D.C. Mitochondria and cancer. Nat. Rev. Cancer 2012, 12:685-698.
39. Warburg O. On the origin of cancer cells. Science 1956, 123:309-314.
40. Pencheva N., Tavazoie S.F. Control of metastatic progression by microRNA regulatory networks. Nat. Cell Biol. 2013, 15:546-554.
41. Cha Y.H., Kim N.H., Park C., Lee I., Kim H.S., Yook J.I. MiRNA-34 intrinsically links p53 tumor suppressor and Wnt signaling. Cell Cycle 2012, 11:1273-1281.
42. Trapnell C., Williams B.A., Pertea G., Mortazavi A., Kwan G., van Baren M.J., Salzberg S.L., Wold B.J., Pachter L. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat. Biotechnol. 2010, 28:511-515.
43. Li H., Handsaker B., Wysoker A., Fennell T., Ruan J., Homer N., Marth G., Abecasis G., Durbin R. The sequence alignment/map format and SAMtools. Bioinformatics 2009, 25:2078-2079.
44. Kozomara A., Griffiths-Jones S. miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res. 2011, 39:D152-D157.
45. Hofacker I.L., Stadler P.F. Memory efficient folding algorithms for circular RNA secondary structures. Bioinformatics 2006, 22:1172-1176.
46. Maere S., Heymans K., Kuiper M. BiNGO: a Cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks. Bioinformatics 2005, 21:3448-3449.
47. Shannon P., Markiel A., Ozier O., Baliga N.S., Wang J.T., Ramage D., Amin N., Schwikowski B., Ideker T. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003, 13:2498-2504.